Good news from Australia with a possible new treatment for BV! VivaGel is a topical vaginal gel tested in a Phase 2 clinical trial in 132 women resulting in 74% of patients achieving Clinical Cure of BV 2 to 5 days after completion of therapy compared with just 22% in the placebo group.
The results are comparable in efficacy to antibiotics but without the common side effects.
The treatment’s not available yet but plans are now underway for the Phase 3 (and final) trial to commence later this year.
So good to see some developments in women’s health, especially for an infection that’s so common.
The results of this trial are pretty interesting.